Evidence map›Paper›PMID 21709145›Full record

ReviewEpidemiologic reviews2011

Genetic screening.

Wylie Burke, Beth Tarini, Nancy A Press, James P Evans

Abstract readReview
In one paragraph

Review in Epidemiologic reviews, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. The evolution of prenatal care delivery guidelines in the United States.American journal of obstetrics and gynecology · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. International journal of medical sciences · 2018
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Wylie BurkeDepartment of Bioethics and Humanities, A204 Health Sciences Building, Box 357120, University of Washington, Seattle, WA 98195, USA. wburke@u.washington.edu
Beth Tarini
Nancy A Press
James P Evans

Funding

Genomic Health Care and the Medically UnderservedP50HG003374 · NHGRI · UNIVERSITY OF WASHINGTON · PI BURKE, WYLIE G. · 2004 to 2014
$9.8M
Improving Healthcare Delivery for Infants with Positive Newborn Screening ResultsK23HD057994 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TARINI, BETH A · 2009 to 2013
$662k
NHGRI NIH HHS P50 HG003374NHGRI NIH HHS P50 HG 3374NICHD NIH HHS K23 HD057994NICHD NIH HHS K23HD057994
6 · The paper itself

Abstract

Current approaches to genetic screening include newborn screening to identify infants who would benefit from early treatment, reproductive genetic screening to assist reproductive decision making, and family history assessment to identify individuals who would benefit from additional prevention measures. Although the traditional goal of screening is to identify early disease or risk in order to implement preventive therapy, genetic screening has always included an atypical element-information relevant to reproductive decisions. New technologies offer increasingly comprehensive identification of genetic conditions and susceptibilities. Tests based on these technologies are generating a different approach to screening that seeks to inform individuals about all of their genetic traits and susceptibilities for purposes that incorporate rapid diagnosis, family planning, and expediting of research, as well as the traditional screening goal of improving prevention. Use of these tests in population screening will increase the challenges already encountered in genetic screening programs, including false-positive and ambiguous test results, overdiagnosis, and incidental findings. Whether this approach is desirable requires further empiric research, but it also requires careful deliberation on the part of all concerned, including genomic researchers, clinicians, public health officials, health care payers, and especially those who will be the recipients of this novel screening approach.

Indexed as

Genetic TestingDiagnostic ErrorsDown SyndromeFemaleGenetic Carrier ScreeningGenetic Predisposition to DiseaseHumansInfant, NewbornMass ScreeningPregnancyPrenatal DiagnosisPrimary Health Care

Identifiers

PMID21709145
PMCPMC3166195

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.